Fundz

MATI THERAPEUTICS ANNOUNCES PROMOTION OF CHRIS MULLER TO CHIEF OPERATING OFFICER

PRIVATESep 26, 2023

Company

Mati Therapeutics

AustinBiotechnologyHealth CareMedicalTherapeutics

Description

Mati Therapeutics Inc. announced that it has promoted Chris Muller to the position of Chief Operating Officer. He formerly held the position of Chief Commercial Officer

Quick answer

MATI THERAPEUTICS ANNOUNCES PROMOTION OF CHRIS MULLER TO CHIEF OPERATING OFFICER (September 26, 2023). Mati Therapeutics is based in Austin, Texas, United States.

What did Mati Therapeutics announce on September 26, 2023?
Mati Therapeutics Inc. announced that it has promoted Chris Muller to the position of Chief Operating Officer.
What does Mati Therapeutics do?
Mati Therapeutics is an Austin-based company developing a non-invasive, sustained drug delivery platform to treat ocular diseases such as glaucoma.
Where is Mati Therapeutics based?
Mati Therapeutics is based in Austin, Texas, United States.
Which similar companies made leadership changes around the same time?
Strata Oncology (September 26, 2023), Arcutis (September 27, 2023), Faeth Therapeutics (September 29, 2023) and Nanoscope Therapeutics (September 21, 2023) also announced leadership changes within 45 days of Mati Therapeutics.

Source: Fundz verified event record.

Other recent leadership changes in Medical and Therapeutics

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Mati Therapeutics, and when

A new leader at Mati Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Mati Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Mati Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Mati Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Mati Therapeutics

Location

101 Colorado Street

Austin, Texas, United States

About

Mati Therapeutics is an Austin-based company developing a non-invasive, sustained drug delivery platform to treat ocular diseases such as glaucoma. Its proprietary Evolute® Punctal Plug Delivery System provides continuous, automated medication delivery, improving patient outcomes and eliminating the need for eye drops. Founded by industry veterans from Allergan, AMO, Abbott Laboratories, and QLT Inc., Mati brings over a century of combined ophthalmic expertise to advancing sustained therapy solutions for eye care.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Mati Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Chris
Senior decision-maker at this company
••••••••@••••••••

See Chris's verified email →

Jonathan
Likely contact at this company
••••••••@••••••••

See Jonathan's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Mati Therapeutics's next move

Learn about Strategic plan

Mati Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.